Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02868151Phase 3Completed
Phase 3, randomised, open-label trial of ascorbic acid in oral mucositis (OM) (3 arms), sponsored by Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre. Primary endpoint: World Health Organization criteria of grading oral mucositis at 1.5 years. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02868151.